We are monitoring the impact of COVID-19 on Europe In-Vitro Toxicology Testing Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 200
Share on
Share on

Europe In-Vitro Toxicology Testing Market Research Report – Segmented By Product, Type, Toxicity Endpoints & Tests, Technology, Method, Industry and Country (UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe) – Analysis on Size, Share, Trends, Growth, Forecast (2021 to 2026)

Pulished: April, 2021
ID: 200
Pages: 138

European In-Vitro Toxicology Testing Market Size (2021 to 2026)

The size of the In-vitro toxicology testing market in Europe is expected to reach USD 12128.43 Million by 2026 from USD 6597.41 Million in 2021, growing at a CAGR of 12.95% during the forecast period.

In-vitro toxicology testing is the scientific analysis of toxic effects produced by chemical substances on cultured mammalian cells or bacteria. Toxicity testing is essential in drug discovery as it identifies the poisonous effects of a new compound in the early stages of drug discovery. This early detection of toxicity reduces the development cost and time.

Increasing chronic diseases, growing aging population, rising technological advancements, growing demand for a healthy lifestyle, availability of government-supported anti-animal testing laws, and the existence of favorable regulatory policies (such as European government banned the production & sale of all animal-tested cosmetics in Europe) are driving the growth of in-vitro toxicology testing market in Europe. However, the high cost of technologies and lack of awareness on the in-vitro toxicology testing utilization are restraining the growth of the in-vitro toxicology testing market in Europe.

This research report segmented and sub-segmented into the following categories:

  • By Product: Assays, Reagents & Labware and Services
  • By Type: ADME, Dose and Toxic Substance
  • By Toxicity Endpoints & Tests: Carcinogenicity, Dermal Toxicity and Genotoxicity
  • By Technology: OMICS Technologies and Cell Culture Technology
  • By Method: Cellular Assays and In-Silico Method
  • By Industry: Cosmetics & Household Products and Pharmaceutical
  • By Country: UK, France, Spain, Germany, Italy, Russia, Sweden, Denmark, Switzerland, Netherlands, Turkey, Czech Republic and Rest of Europe

Based on product type, the Assays segment is estimated to command the largest share of Europe in-vitro toxicology testing market by product in 2019. Systemic toxicity is assessed to control Europe's largest share in-vitro toxicology testing market by toxicity endpoints & tests in 2019. Technology is further segmented as OMICS technologies & cell culture technology.

Based on Method, the In-silico method is estimated to command the largest share of Europe in-vitro toxicology testing market by the method in 2016. The cosmetics & household products industry is expected to account for the largest market share of Europe in-vitro toxicology testing market by industry in 2019.

Based on the region, Germany is estimated to account for the largest share of the Europe in-vitro toxicology testing market in 2019. In contrast, France is expected to grow at the highest CAGR during the forecast period.

Companies dominating European In-Vitro Toxicology Market profiled in this report are Covance, Inc. (A subsidiary of LabCorp) (U.S.), Agilent Technologies, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Eurofins Scientific SE (Luxembourg), General Electric Company (U.S.), BioReliance, Inc. (U.S.), Charles River Laboratories International, Inc. (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Catalent (U.S.) and Cyprotex (U.K.).

1. Introduction                                                                 

                1.1 Market Definition                                                    

                1.2 Study Deliverables                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                          

                1.4 General Study Assumptions                                                

2. Research Methodology                                                                           

                2.1 Introduction                                                               

                2.2 Research Phases                                                      

                                2.2.1 Secondary Research                                           

                                2.2.2 Primary Research                                 

                                2.2.3 Econometric Modelling                                      

                                2.2.4 Expert Validation                                  

                2.3 Analysis Design                                                         

                2.4 Study Timeline                                                          

3. Overview                                                                       

                3.1 Executive Summary                                                

                3.2 Key Inferences                                                         

                3.3 New Developments                                                               

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                                                    

                4.1 Market Drivers                                                          

                4.2 Market Restraints                                                    

                4.3 Key Challenges                                                         

                4.4 Current Opportunities in the Market                                                              

5. Market Segmentation                                                                              

                5.1 Product                                        

                                5.1.1 Introduction                                           

                                5.1.2 Assays                                       

                                5.1.3 Reagents & Labware                                           

                                5.1.4 Services     Growth Hormone Therapy                         

                5.2 Type                                              

                                5.2.1 Introduction                                           

                                5.2.2 ADME (Absorption, Distribution, Metabolism, and Excretion)                                          

                                5.2.3 Dose                                          

                                5.2.4 Toxic Substance                                    

                5.3 Toxicity Endpoints & Tests                                   

                                5.3.1 Introduction                                           

                                5.3.2 Systemic Toxicity                                  

                                5.3.3 Dermal Toxicity                                     

                                5.3.4 Carcinogenicity                                      

                                5.3.5 Ocular Toxicity                                       

                                5.3.6 Skin Sensitization & Irritation                                          

                                5.3.7 Genotoxicity                                          

                                5.3.8 Neurotoxicity                                         

                                5.3.9 Organ Toxicity                                        

                                5.3.10 Other Toxicity Endpoints & Tests                                

                5.4 Technology                                 

                                5.4.1 Introduction                                           

                                5.4.2 OMICS Technologies                                           

                                5.4.3 Cell Culture Technology                                     

                                5.4.4 High-Throughput Technologies                                      

                                5.4.5 Molecular Imaging Technologies                                   

                5.5 Method                                       

                                5.5.1 Introduction                                           

                                5.5.2 In-Silico Methods                                 

                                5.5.3 Biochemical Assays                                              

                                5.5.4 Cellular Assays                                       

                                5.5.5 Ex-Vivo Models                                     

                5.6 Industry                                       

                                5.6.1 Introduction                                           

                                5.6.2 Cosmetics and Household Products                                             

                                5.6.3 Diagnostics                                              

                                5.6.4 Pharmaceuticals                                   

                                5.6.5 Food Industry                                        

                                5.6.6 Chemicals                                

6. Geographical Analysis                                                                              

                                6.1 Introduction                                               

                                6.2 U.K                                 

                                6.3 Spain                                             

                                6.4 Germany                                     

                                6.5 Italy                                               

                                6.6 France                                          

7. Strategic Analysis                                                                       

                7.1 PESTLE analysis                                                         

                                7.1.1 Political                                     

                                7.1.2 Economic                                 

                                7.1.3 Social                                         

                                7.1.4 Technological                                         

                                7.1.5 Legal                                          

                                7.1.6 Environmental                                       

                7.2 Porter’s Five analysis                                                              

                                7.2.1 Bargaining Power of Suppliers                                        

                                7.2.2 Bargaining Power of Consumers                                    

                                7.2.3 Threat of New Entrants                                     

                                7.2.4 Threat of Substitute Products and Services                                              

                                7.2.5 Competitive Rivalry within the Industry                                     

8. Market Leaders' Analysis                                                                        

                8.1 Covance, Inc.  (A subsidiary of LabCorp) (U.S.)                                            

                                8.1.1 Overview                                 

                                8.1.2 Product Analysis                                   

                                8.1.3 Strategic Evaluation and Operations                                            

                                8.1.4 Financial analysis                                  

                                8.1.5 Legal issues                                             

                                8.1.6 Recent Developments                                       

                                8.1.7 SWOT analysis                                       

                                8.1.8 Analyst View                                          

                8.2 Agilent Technologies, Inc. (U.S.)                                        

                8.3 Bio-Rad Laboratories, Inc. (U.S.)                                        

                8.4 Eurofins Scientific SE (Luxembourg)                                 

                8.5 General Electric Company (U.S.)                                       

                8.6 BioReliance, Inc. (U.S.)                                      

                8.7 Charles River Laboratories International, Inc. (U.S.)                                  

                8.8 Thermo Fisher Scientific, Inc. (U.S.)                                 

                8.9 Catalent (U.S.)                                          

                8.10 Cyprotex (U.K.)                                      

9. Competitive Landscape                                                                           

                9.1 Market share analysis                                                            

                9.2 Merger and Acquisition Analysis                                                       

                9.3 Agreements, collaborations and Joint Ventures                                                         

                9.4 New Product Launches                                                         

10. Expert Opinions                                                                        

                10.1 Market Outlook                                                     

                10.2 Investment Opportunities                                                 

Appendix                                                                           

                a) List of Tables                                                

                b) List of Figures                                                              

  • Regional, and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Europe In-Vitro Toxicology Testing Market, By Region, From 2021 to 2026 (USD Million)    
  2. Europe In-Vitro Toxicology Testing Market, By Product, From 2021 to 2026 (USD Million)  
  3. Europe Assays Market, By Region, From 2021 to 2026 (USD Million)            
  4. Europe Reagents & Labware Market, By Region, From 2021 to 2026 (USD Million)
  5. Europe Services Market, By Region, From 2021 to 2026 (USD Million)         
  6. Europe In-Vitro Toxicology Testing Market, By Type, From 2021 to 2026 (USD Million)        
  7. Europe ADME (Absorption, Distribution, Metabolism, and Excretion) Market, By Region, From 2021 to 2026 (USD Million)
  8. Europe Dose Market, By Region, From 2021 to 2026 (USD Million)
  9. Europe Toxic Substance Market, By Region, From 2021 to 2026 (USD Million)          
  10. Europe In-Vitro Toxicology Testing Market, By Toxicity Endpoints & Tests, From 2019-2024 ( USD Million )
  11. Europe Systemic Toxicity Market, By Region, From 2021 to 2026 (USD Million)        
  12. Europe Dermal Toxicity Market, By Region, From 2021 to 2026 (USD Million)           
  13. Europe Carcinogenicity Market, By Region, From 2021 to 2026 (USD Million)           
  14. Europe Ocular Toxicity Market, By Region, From 2021 to 2026 (USD Million)             
  15. Europe Skin Sensitization & Irritation Market, By Region, From 2021 to 2026 (USD Million)
  16. Europe Genotoxicity Market, By Region, From 2021 to 2026 (USD Million)
  17. Europe Neurotoxicity Market, By Region, From 2019-2024 ( USD Million )
  18. Europe Organ Toxicity Market, By Region, From 2021 to 2026 (USD Million)             
  19. Europe Other Toxicity Endpoints & Tests Market, By Region, From 2021 to 2026 (USD Million)        
  20. Europe In-Vitro Toxicology Testing Market, By Technology, From 2021 to 2026 (USD Million)           
  21. Europe OMICS Technologies Market, By Region, From 2021 to 2026 (USD Million)
  22. Europe Cell Culture Technology Market, By Region, From 2021 to 2026 (USD Million)          
  23. Europe High-Throughput Technologies Market, By Region, From 2021 to 2026 (USD Million)            
  24. Europe Molecular Imaging Technologies Market, By Region, From 2021 to 2026 (USD Million)         
  25. Europe In-Vitro Toxicology Testing Market, By Method, From 2021 to 2026 (USD Million)  
  26. Europe In-Silico Methods Market, By Region, From 2021 to 2026 (USD Million)       
  27. Europe Biochemical Assays Market, By Region, From 2021 to 2026 (USD Million)   
  28. Europe Cellular Assays Market, By Region, From 2021 to 2026 (USD Million)            
  29. Europe Ex-Vivo Models Market, By Region, From 2021 to 2026 (USD Million)          
  30. Europe In-Vitro Toxicology Testing Market, By Industry, From 2021 to 2026 (USD Million) 
  31. Europe Cosmetics and Household Products Market, By Region, From 2021 to 2026 (USD Million)   
  32. Europe Diagnostics Market, By Region, From 2021 to 2026 (USD Million)   
  33. Europe Pharmaceuticals Market, By Region, From 2021 to 2026 (USD Million)         
  34. Europe Food Industry Market, By Region, From 2019-2024 ( USD Million )
  35. Europe Chemicals Market, By Region, From 2021 to 2026 (USD Million)      
  36. U.K. In-Vitro Toxicology Testing Market, By Product, From 2021 to 2026 (USD Million)         
  37. U.K. In-Vitro Toxicology Testing Market, By Type, From 2019-2024 ( USD Million )
  38. U.K. In-Vitro Toxicology Testing Market, By Toxicity Endpoints & Tests, From 2021 to 2026 (USD Million)    
  39. U.K. In-Vitro Toxicology Testing Market, By Technology, From 2021 to 2026 (USD Million) 
  40. U.K. In-Vitro Toxicology Testing Market, By Method, From 2021 to 2026 (USD Million)        
  41. U.K. In-Vitro Toxicology Testing Market, By Industry, From 2021 to 2026 (USD Million)       
  42. Germany In-Vitro Toxicology Testing Market, By Product, From 2019-2024 ( USD Million )
  43. Germany In-Vitro Toxicology Testing Market, By Type, From 2021 to 2026 (USD Million)    
  44. Germany In-Vitro Toxicology Testing Market, By Toxicity Endpoints & Tests, From 2021 to 2026 (USD Million)         
  45. Germany In-Vitro Toxicology Testing Market, By Technology, From 2021 to 2026 (USD Million)       
  46. Germany In-Vitro Toxicology Testing Market, By Method, From 2021 to 2026 (USD Million)             
  47. Germany In-Vitro Toxicology Testing Market, By Industry, From 2021 to 2026 (USD Million)             
  48. France In-Vitro Toxicology Testing Market, By Product, From 2021 to 2026 (USD Million)   
  49. France In-Vitro Toxicology Testing Market, By Type, From 2021 to 2026 (USD Million)          
  50. France In-Vitro Toxicology Testing Market, By Toxicity Endpoints & Tests, From 2021 to 2026 (USD Million)
  51. France In-Vitro Toxicology Testing Market, By Technology, From 2021 to 2026 (USD Million)            
  52. France In-Vitro Toxicology Testing Market, By Method, From 2021 to 2026 (USD Million)   
  53. France In-Vitro Toxicology Testing Market, By Industry, From 2021 to 2026 (USD Million)  
  54. Italy In-Vitro Toxicology Testing Market, By Product, From 2021 to 2026 (USD Million)        
  55. Italy In-Vitro Toxicology Testing Market, By Type, From 2019-2024 ( USD Million )
  56. Italy In-Vitro Toxicology Testing Market, By Toxicity Endpoints & Tests, From 2021 to 2026 (USD Million)    
  57. Italy In-Vitro Toxicology Testing Market, By Technology, From 2021 to 2026 (USD Million) 
  58. Italy In-Vitro Toxicology Testing Market, By Method, From 2021 to 2026 (USD Million)        
  59. Italy In-Vitro Toxicology Testing Market, By Industry, From 2021 to 2026 (USD Million)       
  60. Spain In-Vitro Toxicology Testing Market, By Product, From 2021 to 2026 (USD Million)      
  61. Spain In-Vitro Toxicology Testing Market, By Type, From 2021 to 2026 (USD Million)            
  62. Spain In-Vitro Toxicology Testing Market, By Toxicity Endpoints & Tests, From 2021 to 2026 (USD Million) 
  63. Spain In-Vitro Toxicology Testing Market, By Technology, From 2021 to 2026 (USD Million)
  64. Spain In-Vitro Toxicology Testing Market, By Method, From 2021 to 2026 (USD Million)     
  65. Spain In-Vitro Toxicology Testing Market, By Industry, From 2021 to 2026 (USD Million)     

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample